170 related articles for article (PubMed ID: 31338847)
1. An additive boundary for group sequential designs with connection to conditional error.
Xi D; Gallo P
Stat Med; 2019 Oct; 38(23):4656-4669. PubMed ID: 31338847
[TBL] [Abstract][Full Text] [Related]
2. A general formulation for a one-sided group sequential design.
Moser BK; George SL
Clin Trials; 2005; 2(6):519-28. PubMed ID: 16422312
[TBL] [Abstract][Full Text] [Related]
3. Group sequential design for historical control trials using error spending functions.
Wu J; Li Y
J Biopharm Stat; 2020 Mar; 30(2):351-363. PubMed ID: 31718458
[TBL] [Abstract][Full Text] [Related]
4. Group sequential designs using a family of type I error probability spending functions.
Hwang IK; Shih WJ; De Cani JS
Stat Med; 1990 Dec; 9(12):1439-45. PubMed ID: 2281231
[TBL] [Abstract][Full Text] [Related]
5. Implementing type I & type II error spending for two-sided group sequential designs.
Rudser KD; Emerson SS
Contemp Clin Trials; 2008 May; 29(3):351-8. PubMed ID: 17933592
[TBL] [Abstract][Full Text] [Related]
6. Futility interim monitoring with control of type I and II error probabilities using the interim Z-value or confidence limit.
Lachin JM
Clin Trials; 2009 Dec; 6(6):565-73. PubMed ID: 19933716
[TBL] [Abstract][Full Text] [Related]
7. CP function: an alpha spending function based on conditional power.
Jiang Z; Wang L; Li C; Xia J; Wang W
Stat Med; 2014 Nov; 33(26):4501-14. PubMed ID: 25100033
[TBL] [Abstract][Full Text] [Related]
8. On adaptive error spending approach for group sequential trials with random information levels.
Liu Q; Lim P; Nuamah I; Li Y
J Biopharm Stat; 2012; 22(4):687-99. PubMed ID: 22651109
[TBL] [Abstract][Full Text] [Related]
9. Flexible implementations of group sequential stopping rules using constrained boundaries.
Burington BE; Emerson SS
Biometrics; 2003 Dec; 59(4):770-7. PubMed ID: 14969454
[TBL] [Abstract][Full Text] [Related]
10. Flexible stopping boundaries when changing primary endpoints after unblinded interim analyses.
Chen LM; Ibrahim JG; Chu H
J Biopharm Stat; 2014; 24(4):817-33. PubMed ID: 24697500
[TBL] [Abstract][Full Text] [Related]
11. A gatekeeping procedure to test a primary and a secondary endpoint in a group sequential design with multiple interim looks.
Tamhane AC; Gou J; Jennison C; Mehta CR; Curto T
Biometrics; 2018 Mar; 74(1):40-48. PubMed ID: 28589692
[TBL] [Abstract][Full Text] [Related]
12. Bayesian decision-theoretic group sequential clinical trial design based on a quadratic loss function: a frequentist evaluation.
Lewis RJ; Lipsky AM; Berry DA
Clin Trials; 2007; 4(1):5-14. PubMed ID: 17327241
[TBL] [Abstract][Full Text] [Related]
13. Upstrapping to determine futility: predicting future outcomes nonparametrically from past data.
Wild JL; Ginde AA; Lindsell CJ; Kaizer AM
Trials; 2024 May; 25(1):312. PubMed ID: 38725072
[TBL] [Abstract][Full Text] [Related]
14. Optimal spending functions for asymmetric group sequential designs.
Anderson KM
Biom J; 2007 Jun; 49(3):337-45. PubMed ID: 17623339
[TBL] [Abstract][Full Text] [Related]
15. Optimality criteria for futility stopping boundaries for group sequential designs with a continuous endpoint.
Li X; Herrmann C; Rauch G
BMC Med Res Methodol; 2020 Nov; 20(1):274. PubMed ID: 33153438
[TBL] [Abstract][Full Text] [Related]
16. A review of methods for futility stopping based on conditional power.
Lachin JM
Stat Med; 2005 Sep; 24(18):2747-64. PubMed ID: 16134130
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Bayesian and frequentist group-sequential clinical trial designs.
Stallard N; Todd S; Ryan EG; Gates S
BMC Med Res Methodol; 2020 Jan; 20(1):4. PubMed ID: 31910813
[TBL] [Abstract][Full Text] [Related]
18. Computations for group sequential boundaries using the Lan-DeMets spending function method.
Reboussin DM; DeMets DL; Kim KM; Lan KK
Control Clin Trials; 2000 Jun; 21(3):190-207. PubMed ID: 10822118
[TBL] [Abstract][Full Text] [Related]
19. A Bayesian sequential design using alpha spending function to control type I error.
Zhu H; Yu Q
Stat Methods Med Res; 2017 Oct; 26(5):2184-2196. PubMed ID: 26187736
[TBL] [Abstract][Full Text] [Related]
20. Testing a primary and a secondary endpoint in a group sequential design.
Tamhane AC; Mehta CR; Liu L
Biometrics; 2010 Dec; 66(4):1174-84. PubMed ID: 20337631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
